• WHAT WE DO
  • Strategy
  • Trial Solutions
  • Bio-Partnering
  • Contact Us
  • Our partnerships with biotech and pharma recognize superior science and effective business strategies
  • Strategic use of imaging & AI accelerates drug development
  • Medical imaging optimises patient selection & trial outcomes
  • IAG's DYNAMIKA optimizes trial management & provides real-time visibility of trial progress
IAG, Image Analysis Group

Our expert, technology and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.

Imaging Services in Clinical Trials

We strategically use imaging, such as MRI, CT, and PET to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a successful H2H or superiority trial, our science, operations and technology teams will work with you to develop the right solution

DYNAMIKA, Leading Trial Platform

IAG’s cloud platform for robust imaging data management in multi-centre trial setting and central review. One comprehensive software system to control trial progress, conduct central reads and use built-in AI for earlier read-outs and decision support.

Certified: ISO13485, FDA510K, CE, 21 CFR Part 11

Contact Us
Careers

In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.

Events

2021 © IAG

T (US): + 1 215 454 0717

T (UK): +44 7413 022053

contact@ia-grp.com